Market LIVE
Published markets; coverage varies by country
Product profile · United States

PERSERIS KIT

 ·  Patent Litigation & Settlement History ↓

IngredientRISPERIDONE
Application typeNDA
Application210655
Product002
Dosage formFOR SUSPENSION, EXTENDED RELEASE
RouteSUBCUTANEOUS
Strength120MG
Approval date2018-07-27
Marketing statusDiscontinued
Status event—
ApplicantINDIVIOR
Product source

Current GenericRadar decision

Year2026
SelectionDISCONTINUED
ReviewFINAL
Anchor typeDISCONTINUED
Anchor date—
Patent anchor—
Exclusivity anchor2021-07-27
Protection date—
First Final ANDA—
Status event—

GNR judgment: DISCONTINUED. Reference year: 2026. Anchor type: DISCONTINUED. Patent anchor: not recorded. Exclusivity anchor: 2021-07-27. Anchor date: not recorded. Patent tail: not established. Exclusivity tail: not established. Review status: FINAL. Historical detailed rationale is retained in the evidence snapshot; this is a structured English summary, not a literal translation.

Patent estate

PatentEffective dateOfficial listingTRUE_DSDS gradeClaim classification / basisPTEPEDFamily
104061602026-06-26DP/U U-2608———
———
100585542026-09-26U U-2363———
———
95974022026-09-26DP ————
———
111100932026-11-05DP/U U-3135———
———
100106122028-02-13DP ————
———
103765902028-02-13U U-2608———
———
110138092028-02-13DP/U U-3135———
———
117124752028-02-13U U-3135———
———
91801972028-02-13DP ————
———
91864132028-02-13U U-543———
———

Regulatory exclusivity

CodeStart dateEnd dateScopeEntire productAll indicationsFull coverage dateCombinationSource
No exclusivity facts are recorded in this product snapshot.

2026-10-10 · NO_RECORD_IN_CURRENT_SNAPSHOT · Historical coverage: NOT_COMPLETE

Generic approval evidence

Application / productEventFinal dateTentative dateApplicantAuthorized genericExact mappingSource
No generic approval facts are linked to this product.

Market Entry Information

API filings, authorized generics and linked regulatory milestones.

API Master Files & Certifications 0 records

Ingredient-level registrations from linked public manufacturer portfolios. A filing does not establish supply to this finished product. DMFs are not FDA approvals.

APIHolder / manufacturerHolder countryFiling typeNumberStatusFiled dateAvailable for referenceSourceLast verified
No master-file or certification records are linked through public manufacturer portfolios.

Authorized Generics 0 records

Authorized generics are shown separately from independent ANDA approvals.

Application / productApplicantEvent / status First marketed Product mappingSourceLast verified
No authorized-generic records are linked to this product.

Tentative ANDA Approvals 0 records

Tentative approval is not final approval. Historical tentative approvals remain visible after a linked final approval.

Application / productApplicantEvent / status Tentative date Follow-up final approvalProduct mappingSourceLast verified
No tentative-approval records are linked to this product.

Paragraph IV Challenges 0 records

Paragraph IV challenges below are sourced from legal records separately from FDA approvals. An ANDA filing, lawsuit or settlement does not establish final approval or commercial launch.

Application / productApplicantEvent / status Certification event date Product mappingSourceLast verified
No structured Paragraph IV certification events are linked in the available approval evidence.

Final ANDA Approvals 0 records

Approval dates do not establish commercial launch. Product mapping is shown for each linked record.

Application / productApplicantEvent / status Final approval date Product mappingSourceLast verified
No final-approval records are linked to this product.
Independent legal-event information

Litigation & Settlement History

Settlement launch rights generally apply only to the named parties and product scope. These records do not change GenericRadar patent/exclusivity anchors or current decisions.

No litigation or settlement record currently linked to this product.